CNS involvement and treatment with interferon-alpha are independent prognostic factors in Erdheim-Chester disease: a multicenter survival analysis of 53 patients. Blood 2011 Mar;117(10:)2778-2782.
Erdheim-Chester Disease: a comprehensive review of the literature. Orphanet J Rare Dis 2013 Sep;8(1:)1375.
Erdheim-Chester disease presenting with cutaneous involvement: a case report and literature review. J Cutan Pathol 2011 Mar;38(3:)280-285.
Cerebral, facial, and orbital involvement in Erdheim-Chester disease: CT and MR imaging findings. Radiology 2010 May;255(2:)586-594.
Pituitary tumors: inflammatory and granulomatous expansive lesions of the pituitary. Best Pract Res Clin Endocrinol Metab 2009 Oct;23(5:)639-650.
Erdheim-Chester disease. Clinical and radiologic characteristics of 59 cases. Medicine 1996 May;75(3:)157-169.
Erdheim-Chester disease in a child. Med Pediatr Oncol 2003 Dec;41(6:)575-577.
Treatment of pediatric Erdheim-Chester disease with interleukin-1-targeting drugs. Arthritis Rheum 2011 Dec;63(12:)4031-4032.
Variability in the efficacy of interferon-alpha in Erdheim-Chester disease by patient and site of involvement: results in eight patients. Arthritis Rheum 2006 Oct;54(10:)3330-3336.
Erdheim-Chester disease in childhood: a challenging diagnosis and treatment. J Pediatr Hematol Oncol 2009 Oct;31(10:)782-786.
